Sign in
4

Changes in Ownership

Candel Therapeutics, Inc. Filed Acc 0000950170-24-132932

Chief Technology Officer sold 20,392 shares at $4.56 ($92,898)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Tyagarajan Seshu Chief Technology Officer 2024-11-29 Sale −20,392 $4.56 $92,898 125,657 D
Open-market sales · 20,392 sh · avg $4.56 · $92,898
Loading xslF345X05/ownership.xml…